Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04534010 · ClinicalTrials.gov registry record · NA
Decellularized, Whole Donor Nipple-Areola Complex Reconstruction Grafts
A NA study, sponsored by Stanford University.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT04534010: Clinical Trial NA study, sponsored by Stanford University.
NCT04534010 is a NA study that was terminated before completion, run by Stanford University. The registered enrollment target is 6 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04534010, a NA study, was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
The goal of this study is to evaluate safety and healing time after nipple-areolar complex (NAC) reconstruction with the BioAesthetics' decellularized human nipple-areolar complex (dcl-hNAC) graft in patients who have had autologous breast reconstruction for breast cancer. Secondary objectives will be to assess patient satisfaction, patient well-being, patient self-esteem, patient body image, patient psychological well-being, nipple dimensions and sensitivity following NAC reconstruction surgery with the BioAesthetics' dcl-hNAC graft.
Interventions
- DEVICE NACgraft
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2021-04-28 |
| Est. Completion | 2024-11-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04534010
The ClinicalTrials.gov registry entry for NCT04534010 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which NACgraft is the first listed.
NCT04534010 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04534010 about?
NCT04534010 is a clinical study titled "Decellularized, Whole Donor Nipple-Areola Complex Reconstruction Grafts". The goal of this study is to evaluate safety and healing time after nipple-areolar complex (NAC) reconstruction with the BioAesthetics' decellularized human nipple-areolar complex (dcl-hNAC) graft in patients who have had autologous breast reconstruction for breast cancer. Secondary objectives will ...
What is the current status of trial NCT04534010?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2021-04-28. Estimated completion is 2024-11-21.
What interventions are being tested in trial NCT04534010?
The interventions under investigation include: NACgraft (DEVICE).
Who is sponsoring clinical trial NCT04534010?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.